Related Experiment Video
Updated: May 5, 2026

The Rabbit Blood-shunt Model for the Study of Acute and Late Sequelae of Subarachnoid Hemorrhage: Technical Aspects
Published on: October 2, 2014
Advances in pathogenic mechanisms, diagnostic methods, surgical and non-surgical treatment, and potential recurrence
Dayuan Zhong1, Hui Cheng1, Zhuoyan Xian2
1Nanhai hospital of Traditional Chinese Medicine, Jinan University, Foshan 528200, China; Neurosurgery, Guangdong Hospital of Integrated Traditional Chinese and Western Medicine, Foshan 528200, China.
Chronic Subdural Hematoma (CSDH), a growing neurosurgical concern due to aging populations, involves complex mechanisms beyond vein rupture. Future research aims to refine treatments and address CSDH recurrence.
Area of Science:
- Neurosurgery
- Geriatrics
- Vascular Biology
Background:
- Chronic Subdural Hematoma (CSDH) incidence is rising globally, particularly in aging populations.
- Etiological understanding of CSDH is expanding beyond bridging vein rupture to include angiogenesis, vascular maturation, and inflammation.
- Advancements in scientific technology are driving the evolution of CSDH concepts and treatments.
Purpose of the Study:
- To review the evolving understanding of Chronic Subdural Hematoma (CSDH) pathogenesis.
- To discuss current clinical treatment strategies and their limitations.
- To highlight future research directions for optimizing CSDH management and reducing recurrence.
Main Methods:
- Literature review of current neurosurgical understanding of CSDH.
- Analysis of evolving etiological factors including angiogenesis and inflammation.
- Evaluation of existing clinical treatment guidelines and challenges.
Main Results:
- CSDH understanding now incorporates angiogenesis, vascular maturation, and inflammation.
- Targeted treatment selection is guided by CSDH type, but challenges remain.
- Recurrence factors require further validation and exploration.
Conclusions:
- Continued research into CSDH pathogenesis is crucial for improving treatment efficacy.
- Addressing CSDH recurrence necessitates validating and discovering new recurrent factors.
- Future efforts should focus on developing novel therapeutic strategies and drugs for CSDH.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Bacterial Meningitis II: Pathophysiology
Brain Abscess l: Introduction
Cerebral Edema ll: Pathophysiology

